MEDIPAL HOLDINGS CORPORATION
7459株式会社メディパルホールディングス
Latest half-year results
First half · fiscal year to 2026-03 · filed 2025-11-13For the first half of the fiscal year to 2026-03: Revenue ¥1.90 trillion (+4.0% YoY), Ordinary income ¥34.3 billion (-2.3% YoY), Net income ¥22.1 billion (+1.7% YoY).
| This period | Year on year | |
|---|---|---|
| Revenue | ¥1.9tn | +4.0% |
| Ordinary profit | ¥34.3bn | -2.3% |
| Net profit to owners | ¥22.1bn | +1.7% |
From the securities report on EDINET, which states no forecast. History via /v1/companies/7459/earnings-releases.
Financials
Japan GAAP · consolidated · fiscal year to 2026-03-31- Revenue
- ¥3.8tn
- Net income
- ¥42.5bn
- ROE
- 6.7%
- Equity ratio
- 33.9%
- Dividend / share
- ¥66
- Employees
- 13,024
| Fiscal year | Revenue | Net income | Total assets | Net assets | ROE | EPS | Operating CF |
|---|---|---|---|---|---|---|---|
| 2026-03-31 | ¥3,817.4bn | ¥42.5bn | ¥1,922.0bn | ¥795.4bn | 6.7% | ¥206.67 | ¥46.6bn |
| 2025-03-31 | ¥3,671.3bn | ¥40.3bn | ¥1,825.0bn | ¥757.9bn | 6.6% | ¥193.2 | ¥60.6bn |
| 2024-03-31 | ¥3,558.7bn | ¥41.5bn | ¥1,799.1bn | ¥736.6bn | 7.1% | ¥195.83 | ¥61.8bn |
| 2023-03-31 | ¥3,360.0bn | ¥38.8bn | ¥1,709.7bn | ¥688.1bn | 7.1% | ¥184.82 | ¥16.1bn |
| 2022-03-31 | ¥3,290.9bn | ¥29.4bn | ¥1,709.5bn | ¥649.1bn | 5.6% | ¥140.14 | ¥61.2bn |
Indicators
Computed by us from filings · fiscal year to 2026-03-31| Metric | Value | Percentile among listed companies |
|---|---|---|
| ROE, % | 6.7 | 36.8 |
| Ordinary margin | 0.0198 | 17.3 |
| Equity ratio, % | 33.9 | 18.2 |
| Revenue growth | 0.0398 | 45.3 |
| Net income growth | 0.056 | 41.4 |
| Operating cash flow / assets | 0.0242 | 25.4 |
Results wording balance: +0.31. Proprietary text method; it describes the wording only and does not interpret context.
Via /v1/companies/7459/indicators. Descriptive figures, not a rating and not investment advice.
From other filings
As the company states them/v1/companies/7459/buybacksSegments, votes and tender offers
Stated in EDINET filings/v1/companies/7459/segments/v1/companies/7459/votingOwnership changes
All companies →- 2026-09-02
Silchester International Investors LLP raised holdings in MEDIPAL HOLDINGS CORPORATION (7459) to 11.96% from 11.73%.
- 2026-08-06
Silchester International Investors LLP changed its stated purpose for holding MEDIPAL HOLDINGS CORPORATION (7459): may_make_proposals -> may_make_proposals, shareholder_value_engagement.
- 2026-08-06
Silchester International Investors LLP raised holdings in MEDIPAL HOLDINGS CORPORATION (7459) to 11.73% from 11.71%.
- 2025-03-21
Silchester International Investors LLP reduced holdings in MEDIPAL HOLDINGS CORPORATION (7459) to 11.71% from 11.76%.
- 2023-04-03
Silchester International Investors LLP raised holdings in MEDIPAL HOLDINGS CORPORATION (7459) to 11.76% from 10.22%.
- 2023-01-11
Silchester International Investors LLP raised holdings in MEDIPAL HOLDINGS CORPORATION (7459) to 10.22% from 9.20%.
- 2023-01-11
Holdings of Silchester International Investors LLP in MEDIPAL HOLDINGS CORPORATION (7459) moved above 10% (9.20% -> 10.22%).
- 2022-10-07
Nomura Securities Co.,Ltd. cut holdings in MEDIPAL HOLDINGS CORPORATION (7459) to 4.51% from 6.18%, below the 5% threshold.
- 2022-09-26
Silchester International Investors LLP raised holdings in MEDIPAL HOLDINGS CORPORATION (7459) to 9.20% from 8.19%.
- 2022-07-27
Silchester International Investors LLP raised holdings in MEDIPAL HOLDINGS CORPORATION (7459) to 8.19% from 7.18%.
Trades by 5% holders
From the 60-day trade tables in 5% reports| Holder | Period | Net shares | Net % of shares | Avg. filed price | Range |
|---|---|---|---|---|---|
| Silchester International Investors LLP | 2022-04-20 – 2026-08-19 | +10,993,300 | +4.57pt | ¥1,986.24 | ¥1,670–2,994 |
Net shares and the average are our calculations. Prices are filed prices as stated by the filer, mostly for off-market trades; they are not market prices. Stock lending, custody transfers and option exercises are excluded from net shares. Every row via /v1/companies/7459/trades.
5% filings
Large shareholding reports on 7459| Filed | Filer | Stake | Change | Stated purpose |
|---|---|---|---|---|
| 2026-09-02 | Silchester International Investors LLP | 11.96% | +0.23pt | may make proposals shareholder value engagement |
| 2026-08-06 | Silchester International Investors LLP | 11.73% | +0.02pt | may make proposals shareholder value engagement |
| 2025-03-21 | Silchester International Investors LLP | 11.71% | −0.05pt | may make proposals |
| 2023-04-03 | Silchester International Investors LLP | 11.76% | +1.54pt | may make proposals |
| 2023-01-11 | Silchester International Investors LLP | 10.22% | +1.02pt | may make proposals |
| 2022-10-07 | Nomura Securities Co.,Ltd. | 4.51% | −1.67pt | — |
| 2022-09-26 | Silchester International Investors LLP | 9.20% | +1.01pt | may make proposals |
| 2022-07-27 | Silchester International Investors LLP | 8.19% | +1.01pt | may make proposals |
| 2022-06-14 | Silchester International Investors LLP | 7.18% | +1.06pt | may make proposals |
| 2022-06-07 | Nomura Securities Co.,Ltd. | 6.18% | +1.15pt | — |
Cross-shareholdings
From the annual report's status of shareholdings- Listed strategic holdings
- 41 issues
- Book value
- ¥93.8bn
- Sold in the year
- ¥22.9bn 9 issues
- Bought in the year
- ¥7m 2 issues
- Mutual, both reports
- 25
- Held by listed cos.
- 31
| Holds | Book value | Shares vs. prior year | Mutual |
|---|---|---|---|
| Otsuka Holdings Co., Ltd. 4578 | ¥58.5bn | 0.0% | both reports |
| CREATE SD HOLDINGS CO.,LTD 3148 | ¥5.7bn | +0.1% | no |
| TRIAL Holdings, Inc. 141A | ¥5.0bn | 0.0% | no |
| ㈱ＥＭシステムズ | ¥4.6bn | 0.0% | no |
| ONO PHARMACEUTICAL CO., LTD. 4528 | ¥4.2bn | 0.0% | both reports |
| MatsukiyoCocokara & Co 3088 | ¥3.9bn | +0.2% | no |
| DAIICHI SANKYO COMPANY, LIMITED 4568 | ¥3.6bn | -50.0% | both reports |
| Shionogi & Co.,Ltd. 4507 | ¥3.5bn | 0.0% | both reports |
| エ－ザイ㈱ | ¥3.4bn | 0.0% | stated |
| Takeda Pharmaceutical Company Limited 4502 | ¥2.9bn | 0.0% | no |
Held by: DAIICHI SANKYO COMPANY, LIMITED 4568, Eisai Co., Ltd. 4523, Shionogi & Co.,Ltd. 4507, Otsuka Holdings Co., Ltd. 4578, Nippon Shinyaku Co.,Ltd. 4516, ONO PHARMACEUTICAL CO., LTD. 4528, KYORIN Pharmaceutical Co., Ltd. 4569, KAKEN PHARMACEUTIAL CO., LTD. 4521, SANTEN PHARMACEUTICAL CO.,LTD. 4536, KISSEI PHARMACEUTICAL CO.,LTD. 4547, TSUMURA & CO. 4540, Mochida Pharmaceutical Co.,Ltd. 4534 and 20 more
Purposes, all holdings and mutual flags via /v1/companies/7459/cross-holdings. Share changes include stock splits.
Major shareholders
As of fiscal year end 2026-03-31| Shareholder | Shares | Ratio |
|---|---|---|
| 日本マスタートラスト信託銀行株式会社（信託口） | 30,142,000 | 14.73% |
| individual holder | 10,130,000 | 4.95% |
| 株式会社日本カストディ銀行（信託口） | 8,665,000 | 4.23% |
| individual holder | 5,834,000 | 2.85% |
| individual holder | 5,793,000 | 2.83% |
| 小林製薬株式会社 | 5,074,000 | 2.48% |
| individual holder | 4,310,000 | 2.11% |
| MＰグループメディセオ従業員持株会 | 3,778,000 | 1.85% |
| individual holder | 3,458,000 | 1.69% |
| individual holder | 3,133,000 | 1.53% |
U.S. funds holding 7459
SEC Form N-PORT, reports to 2026-07-31105 U.S. funds held 22,178,828 shares worth $384.0m.
| Fund | Shares | Value | % of fund | As of |
|---|---|---|---|---|
| VANGUARD TOTAL INTERNATIONAL STOCK INDEX FUND VANGUARD STAR FUNDS | 2,804,870 | $50.5m | 0.008% | 2026-07-31 |
| Columbia Overseas Value Fund COLUMBIA FUNDS SERIES TRUST | 2,768,100 | $47.7m | 0.702% | 2026-05-31 |
| Brandes International Small Cap Equity Fund Datum One Series Trust | 2,047,500 | $33.2m | 2.564% | 2026-06-30 |
| VANGUARD DEVELOPED MARKETS INDEX FUND VANGUARD TAX-MANAGED FUNDS | 1,828,956 | $29.6m | 0.009% | 2026-06-30 |
| iShares Core MSCI EAFE ETF iShares Trust | 1,290,800 | $23.2m | 0.012% | 2026-07-31 |
Up to 25 funds per stock via the API.
Get this as JSON
GET /v1/companies/7459
GET /v1/companies/7459/financials
GET /v1/companies/7459/details
GET /v1/companies/7459/segments
GET /v1/companies/7459/voting
GET /v1/companies/7459/tender-offers
GET /v1/companies/7459/indicators
GET /v1/companies/7459/earnings-releases
GET /v1/events?ticker=7459
GET /v1/companies/7459/trades
GET /v1/companies/7459/cross-holdings
GET /v1/companies/7459/brief